In vivo studies on antidiabetic plants used in South African herbal medicine

Journal of Clinical Biochemistry and Nutrition

Volumn 47, Issue 2, 2010, Pages 98-106

  Afolayan, Anthony J ^a   Sunmonu, Taofik O ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Antidiabetic; Blood glucose; Diabetes; Herbal medicines; Plant extract

Indexed keywords

ANTIDIABETIC AGENT; ARTEMISIA AFRA EXTRACT; BRACHYLAENA DISCOLOR EXTRACT; BRACHYLAENA ELLIPTICA EXTRACT; BULBINE NATALENSIS EXTRACT; CANNABIS; CATHA EDULIS EXTRACT; CATHARANTHUS ROSEUS EXTRACT; CHILIANTHUS OLEARACEUS EXTRACT; CHIRONIA BACCIFERA EXTRACT; CISSAMPELOS CAPENSIS EXTRACT; CONYZA SCABRIDA EXTRACT; ELYTROPAPPUS RHINOCEROTIS EXTRACT; GALIUM TOMENTOSUM EXTRACT; GUAVA EXTRACT; HERICHRYSUM NUDIFOLIUM EXTRACT; HERICHRYSUM ODORATISSIMUM EXTRACT; HERICHRYSUM PETIOLARE EXTRACT; HETEROMORPHICA ARBORESCENS EXTRACT; HYPOXIS COLCHICIFOLIA EXTRACT; HYPOXIS HEMEROCALLIDEA EXTRACT; LEONOTIS LEONURUS EXTRACT; MOMORDICA BALSAMINA EXTRACT; MOMORDICA FOETIDA EXTRACT; PETROSELENIUM CRISPUM EXTRACT; RICINUS COMMUNIS EXTRACT; RUTA GRAVEOLENS EXTRACT; SCLEROCARYA BIRREA EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERNONIA AMYGDALINA EXTRACT;

AFRICAN MEDICINE; DIABETES MELLITUS; ETHNOBOTANY; GLUCOSE BLOOD LEVEL; HERBAL MEDICINE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; POPULATION RESEARCH; PREVALENCE; REVIEW; SCHISTOSOMIASIS;

EID: 77956596977     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.09-126R     Document Type: Review

References (90)

1. Khan, A., Zaman, G., and Anderson, R.A.: Bay leaves improve glucose and lipid profile of people with Type 2 diabetes. J. Clin. Biochem. Nutr., 44, 52-56, 2009.
2. Rang, H.P., Dale, M.M., and Ritters, J.M.: The endocrine pancreas and the control of blood glucose, in Pharmacology, eds. By Simmons, B. and Beasley, S., U.K. Longman group Ltd., pp. 403-410, 1991.
3. Knentz, A.J. and Nattras, M.: Diabetic ketoacidosis, non ketotic hyperosmolar coma and lactic acidosis, in Handbook of diabetes, eds. By Pickup, J.C. and Williams, G., (2nd edition). Blackwell Science, pp. 479-494, 1991.
4. Kumar, P.J. and Clark, M.: Textbook of Clinical Medicine, Saunders, London, pp. 1099-1121, 2002.
5. Sharma, A.K.: Diabetes mellitus and its complications: An Update, in Macmillan, eds. By Galadari, E.O., Behara, I., Manchandra, M., Adbulrazzaq, S.K., and Mehra, M. K., New Delhi, 1993.
6. Perkins, R.M., Yuan, C.M., and Welch, P.G.: Dispogenic diabetes insipidus: Report of a novel treatment strategy and literature review. Clin. Exp. Nephrol., 10, 63-67, 2006.
7. Notkins, A.L.: Immunologic and genetic factors in type 1 diabetes. J. Biol. Chem., 277, 43545-43548, 2002.
8. Harrison, L.C. and Honeyman, M.C.: Cow's milk and type 1 diabetes: the real debate is about mucosal immune function. Diabetes, 48, 1501-1507, 1999.
9. Garau, C., Cummings, E., Phoenix, D.A., and Singh, J.: Beneficial effect and mechanism of action of Momordica charantia in the treatment of diabetes mellitus: A mini review. Int. J. Diabet. Metab., 11, 46-55, 2003.
10. Zimmet, P., Dowse, G., Finch, C., Serjeantson, S., and King, H.: The epidemiology and natural history of NIDDM - Lessons from the South Pacific. Diabetes Metab. Rev., 6, 91-124, 1990.
11. Suriyaprom, K., Phonrat, B., Namjuntra, P., Chanchay, S., and Tungtrongchitr, R.: The +299(G>A) resistin gene polymorphism and susceptibility to Type 2 diabetes in Thais. J. Clin. Biochem. Nutr., 44, 104-110, 2009.
12. ε- (Carboxymethyl)lysine and coronary atherosclerosis-associated low density lipoprotein abnormalities in Type 2 diabetes: current status. J. Clin. Biochem. Nutr., 44, 14-27, 2009.
13. Harris, A. and Zimmet, P.: Classification of diabetes mellitus and other categories of glucose intolerance, in International Textbook of Diabetes Mellitus, ed. By Alberti, K.G.M., John Wiley & Sons, NY, pp. 9-23, 1997.
14. Miller, C.D., Phillips, L.S., Ziemer, D.C., Gallina, D.L., Cook, C.B., and El-Kebbi, I.M.: Hypoglycemia in patients with type 2 diabetes mellitus. Arch. Intern. Med., 161, 1653-1659, 2001.
15. Zimmet, P., Alberti, K.G., and Shaw, J.: Global and societal implications of diabetes epidemic. Nature, 414, 782-787, 2001.
16. Modak, M., Dixit, P., Londhe, J., Ghaskadbi, S., and Devasagayam, T.P.A.: Indian herbs and herbal drugs used for the treatment of diabetes. J. Clin. Biochem. Nutr., 40, 163-173, 2007.
17. Ali, H., Houghton, P.J., and Soumyanath, A.: α-amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J. Ethnopharmacol., 107, 449-455, 2006.
18. Bailey, C.J. and Day, C.: Traditional plant medicines as treatment for diabetes. Diabetes Care, 12, 553-564, 1989.
19. Marles, R. and Farnsworth, N.R.: Plants as sources of antidiabetic agents. in Economic and Medicinal Plant Research, eds. By Wagner, H. and Farnsworth, N.R., Academic Press Ltd., UK, vol. 6, pp. 149-187, 1994.
20. Joshi, B.S. and Kaul, P.N.: Alternative medicine: herbal drugs and their critical appraisal - Part I. Prog. Drug Res., 56, 1-76, 2001.
21. Erasto, P., Adebola, P.O., Grierson, D.S., and Afolayan, A.J.: An ethnobotanical study of plants used for the treatment of diabetes in Eastern Cape Province, South Africa. Afr. J. Biotechnol., 4, 1458-1460, 2005.
22. Thring, T.S. and Weitz, F.M.: Medicinal plants use in the Bredasdorp/Elim region of the southern Overberg in the Western Cape Province of South Africa. J. Ethnopharmacol., 103, 261-275, 2006.
23. Van Wyk, B.E., de Wet, H., and Van Heerden, F.R.: An ethnobotanical survey of medicinal plants in the southeastern Karoo, South Africa. S. Afr. J. Bot., 74, 696-704, 2008.
24. van de Venter, M., Roux, S., Bungu, L.C., Louw, J., Crouch, N.R., Grace, O.M., Maharaj, V., Pillay, P., Sewnarian, P., Bhagwandin, N., and Folb, P.: Antidiabetic screening and scoring of 11 plants traditionally used in South Africa. J. Ethnopharmacol., 119, 81-86, 2008.
25. Van Wyk, B.E.: A review of Khoi-San and Cape Dutch medical ethnobotany. J. Ethnopharmacol., 119, 331-341, 2008.
26. Van Wyk, B.E.: A broad review of commercially important southern African medicinal plants. J. Ethnopharmacol., 119, 342-355, 2008.
27. Wild, S., Roglic, G., Green, A., Sicree, R., and King, H.: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27, 1047-1053, 2004.
28. Moller, D.E. and Flier, J.S.: Insulin resistance - mechanism, syndromes, and implications. N. Engl. J. Med., 325, 938-948, 1991.
29. American Diabetes Association: Standards of medical care for patients with diabetes mellitus (position statement). Diabetes Care, 20, 518-520, 1997.
30. Levitt, N.S., Katzenellenbongen, J.M., Bradshaw, D., Hoffman, M.N., and Bonnice, F.: The prevalence and identification of risk factor for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care, 16, 601-607, 1993.
31. Erasmus, R.T., Blanco, E.B., Okesina, A.B., Gqweta, Z., and Matsha, T.: Assessment of glycaemic control in stable type 2 black South Africans diabetics attending a peri-urban clinic. Postgrad. Med. J., 75, 603-606, 1999.
32. Van Wyk, B.E., Van Oudtshoorn, B., and Gericke, N.: Medicinal Plants of South Africa, Briza Publications, Pretoria, 1997.
33. Mander, M.: Marketing of indigenous medicinal plants in South Africa. A Case study in Kwa-Zulu Natal, Food and Agricultural Organization of the United Nations, Rome, 1998.
34. Erasto, P., Grierson, D.S., and Afolayan, A.J.: Bioactive sesquiterpene lactones from the leaves of Vernonia amygdalina. J. Ethnopharmacol., 106, 117-120, 2006.
35. Huffman, M.A., Page, J.E., Sukhdeo, M.V.K., Gotoh, S., Kalunde, M.S., and Towers, G.H.N.: Leaf swallowing by chimpanzees: a behavioral adaptation for the control of strong nematode infections. Int. J. Primatol., 72, 475-503, 1996.
36. Riley, H.: Families of flowering plants of Southern Africa, University of Kentucky Press, 170, 1963.
37. Chagnon, M.: General pharmacological inventory of medicinal plants of Rwanda. J. Ethnopharmacol., 12, 239-251, 1984.
38. Akah, P.A. and Ekekwe, R.K.: Ethnopharmacology of some Asteraceae family used in Nigerian traditional medicine. Fitoter, 66, 351-355, 1995.
39. Vlietinck, A.J., Van Hoof, L., Totte, J., Lasure, A., Vanden Berghe, D., Rwangabo, P.C., and Mvukiyumwami, J.: Screening of hundred Rwandese medicinal plants for antimicrobial and antiviral properties. J. Ethnopharmacol., 46, 31-47, 1995.
40. Hamill, F.A., Apio, S., Murbiru, N.K., Mosango, M., Bukenya-Ziraba, R., Maganyi, O.W., and Soejarto, D.D.: Traditional herbal drugs of southern Uganda, I. J. Ethnopharmacol., 70, 281-300, 2000.
41. Kambizi, L. and Afolayan, A.J.: An ethnobotanical study of plants used for the treatment of sexually transmitted diseases (njovhera) in Guruve District, Zimbabwe. J. Ethnopharmacol., 77, 5-9, 2001.
42. Gyang, S.S., Nyam, D.D., and Sokomba, E.N.: Hypoglycaemic activity of Vernonia amygdalina (chloroform extract) in normoglycaemic and alloxan-induced hyperglycaemic rats. J. Pharm. Biores., 1, 61-66, 2004.
43. Ebong, P.E., Atangwho, I.J., Eyong, E.U., and Egbung, G.E.: The antidiabetic efficacy of combined extracts from two continental plants: Azadirachta indica (A. Juss) (Neem) and Vernonia amygdalina (Del.) (African Bitter Leaf). Am. J. Biochem. Biotech., 4, 239-244, 2008.
44. Atangwho, I.J., Ebong, P.E., Egbung, G.E., Eteng, M.U., and Eyong, E.U.: Effect of Vernonia amygdalina Del. on liver function in alloxan-induced hyperglycaemic rats. J. Pharm. Biores., 4, 27-31, 2007.
45. Osinubi, A.A.: Effects of Vernonia amygdalina and chlorpropamide on blood glucose. Med. J. Islamic World Acad. Sci., 16, 115-119, 2008.
46. Okolie, U.V., Okeke, C.E., Oli, J.M., and Ehiemere, I.O.: Hypoglycemic indices of Vernonia amygdalina on postprandial blood glucose concentration of healthy humans. Afr. J. Biotechnol., 7, 4581-4585, 2008.
47. Van Wyk, B.E., Van Oudtshoorn, B., and Gericke, N.: Medicinal Plants of South Africa (2nd ed.), Briza Publications, Pretoria, pp. 156-157, 2002.
48. Watt, J.M. and Breyer-Brandwijk, M.G.: The Medicinal and Poisonous Plants of Southern and Eastern Africa, (2nd ed.), Livingstone, London, pp. 39, 1962.
49. Hutchings, A.: Survey and analysis of traditional medicinal plants as used by the Zulu, Xhosa and Sotho. Bothalia, 19, 111-123, 1989.
50. Pujol, J.: Naturafrica - The Herbalist Handbook, Jean Pujol Natural Healers' Foundation, Durban, South Africa, 1990.
51. Albrecht, C.F.: Hypoxoside: a putative prodrug for the treatment of malignancies, HIV infections, and inflammatory conditions. S. Afr. Med. J., 85, 302-307, 1995.
52. Hutchings, A., Scott, A.H., Lewis, G., and Cunningham, A.B.: Zulu medicinal plants - An inventory, University of Natal Press, Pietermaritzburg, South Africa, 1996.
53. Zibula, S.M.X. and Ojewole, J.A.O.: Hypoglycaemic effects of Hypoxis hemerocallidea corm 'African Potato' methanolic extract in rats. Med. J. Islamic Acad. Sci., 13, 75-78, 2000.
54. Ojewole, J.A.: Antinociceptive, anti-inflammatory and antidiabetic properties of Hypoxis hemerocallidea Fisch. & C.A. Mey. (Hypoxidaceae) corm ['African Potato'] aqueous extract in mice and rats. J. Ethnopharmacol., 103, 126-134, 2006.
55. Mahomed, I.M. and Ojewole, J.A.: Hypoglycemic effect of Hypoxis hemerocallidea corm (African potato) aqueous extract in rats. Methods Find. Exp. Clin. Pharmacol., 25, 617-623, 2003.
56. Musabayane, C.T., Xozwa, K., and Ojewole, J.A.: Effects of Hypoxis hemerocallidea (Fisch. & C.A. Mey.) [Hypoxidaceae] corm (African Potato) aqueous extract on renal electrolyte and fluid handling in the rat. Ren. Fail., 27, 763-770, 2005.
57. Ghosh, R.K. and Gupta, I.: Effect of Vinca rosea and Ficus racemososus on hyperglycemia in rats. Indian J. Animal Health, 19, 145-148, 1980.
58. Chattopadhyay, R.R., Sarkar, S.K., Ganguly, S., Banerjee, R.N., and Basu, T.K.: Hypoglycemic and antihyperglycemic effect of leaves of Vinca rosea Linn. Indian J. Physiol. Pharmacol., 35, 145-151, 1991.
59. Chattopadhyay, R.R., Banerjee, R.N., Sarkar, S.K., Ganguly, S., and Basu, T.K.: Antiinflammatory and acute toxicity studies with leaves of Vinca rosea Linn in experimental animals. Indian J. Physiol. Pharmacol., 36, 291-292.
60. Singh, S.N., Vats, P., Suri, S., Shyam, R., Kumria, M.M., Ranganathan, S., and Sridharan, K.: Effect of an antidiabetic extract of Catharanthus roseus on enzymic activities in streptozotocin induced diabetic rats. J. Ethnopharmacol., 76, 269-277, 2001.
61. Chattopadhyay, R.R.: A comparative evaluation of some blood sugar lowering agents of plant origin. J. Ethnopharmacol., 67, 367-372, 1999.
62. Nammi, S., Boini, M.K., Lodagala, S.D., and Behara, R.B.S.: The juice of fresh leaves of Catharanthus roseus Linn. reduces blood glucose in normal and alloxan diabetic rabbits. BMC Complement. Altern. Med., 3, 1-4, 2003.
63. Iwarsson, M.: Leonotis, in Flora of Southern Africa. Botanical Research Institute, 28, 31-37, 1985.
64. Ojewole, J.A.: Antinociceptive, antiinflammatory and antidiabetic effects of Leonotis leonurus (L.) R. BR. [Lamiaceae] leaf aqueous extract in mice and rats. Methods Find. Exp. Clin. Pharmacol., 27, 257-264, 2005.
65. Maphosa, V., Masika, P., and Adedapo, A.: Safety evaluation of the aqueous extract of Leonotis leonurus shoots in rats. Hum. Exp. Toxicol., 27, 837-843, 2008.
66. Dagne, E.: Botanical Aspects of "Khat" Catha edulis (Celastaceae). Addis Ababa. NAPRECA, 1984.
67. Rudolf, M. and Brenneisn, A.: Khat: The natural amphetamine. Institute of Pharmacy, University of Berne, Baltzerstrasse 5, CH-3012 Berne, Switzerland, 1985.
68. Al-Meshal, I.A., Ageel, A.M., Parmar, N.S., and Tariq, M.: Catha edulis (Khat): Use, Abuse and Current Status of Scientific Knowledge. Fitoter., 56, 131-152, 1985.
69. Kalix, P.: Catha edulis, a plant that has amphetamine effects. Pharm. World Sci., 18, 69-73, 1996.
70. Saif-Ali, R., Al-Qirbi, A., Al-Geiry, A., and Al-Habori, M.: Effect of Catha edulis on plasma glucose and C-peptide in both type 2 diabetics and non-diabetics. J. Ethnopharmacol., 86, 45-49, 2003.
71. Jeffrey, C.: Cucurbitaceae in Flora of Tropical East Africa, Crown Agents, London, 1990.
72. Hakizamungu, E., Van Puyvelde, L., and Wery, M.: Screening of Rwandese medicinal plants for anti-trichomonas activity. J. Ethnopharmacol., 36, 143-146, 1992.
73. Marquis, V.O., Adanlawo, T.A., and Olaniyi, A.A.: The effect of foetidin from Momordica foetida on blood glucose level of albino rats. Planta Med., 31, 367-374, 1977.
74. Eloff, J.N.: Antibacterial activity of Murula (Sclerocarya birrea (A. rich) Hochst. Subsp. Caffra (Sond) Kokwaro) (Anacardiaceae) bark and leaves. J. Ethnopharmacol., 76, 305-308, 2001.
75. Berhaut, J.: Flore Illustrée du Sénégal. Dycotylédones. Tome I. Acanthacées à avicenniacées. Ministère du Développement Rural. Direction des Eaux et Forêt, Dakar, pp. 277-279, 1971.
76. Shackleton, C.: Growth and fruit production of Sclerocarya birrea in the South African lowveld. Agroforestry Systems, 55, 175-180, 2002.
77. Bryant, A.T.: Zulu medicine and medicine men, Cape Town, Struik, 1966.
78. Ojewole, J.A.O.: Hypoglycemic effect of Sclerocarya birrea [(A. Rich.) Hochst.] [Anacardiaceae] stem-bark aqueous extract in rats. Phytomedicine, 10, 675-681, 2003.
79. Dimo, T., Rakotonirina, S.V., Tan, P.V., Azay, J., Dongo, E., Kamtchouing, P., and Cros, G.: Effect of Sclerocarya birrea (Anacardiaceae) stem bark methylene chloride/methanol extract on streptozotocin-diabetic rats. J. Ethnopharmacol., 110, 434-438, 2007.
80. Gondwe, M., Kamadyaapa, D.R., Tufts, M., Chuturgoon, A.A., and Musabayane, C.T.: Sclerocarya birrea [(A. Rich.) Hochst.] [Anacardiaceae] stem-bark ethanolic extract (SBE) modulates blood glucose, glomerular filtration rate (GFR) and mean arterial blood pressure (MAP) of STZ-induced diabetic rats. Phytomedicine, 15, 699-709, 2008.
81. Stone, B.: The flora of Guam. Micronesica, 6, 454-455, 1970.
82. Rios, C.D., Salazar, C.R., Cardona, C., Victoria, K., and Torres, M.: Guayaba. En: Instituto Colombiano Agropecuario. Bogotá (Colombia), second ed. Frutales. Manual de Asistencia Técnica, 4, 221-248, 1977.
83. Mukhtar, H.M., Ansari, S.H., Ali, M., Naved, T., and Bhat, Z.A.: Effect of water extract of Psidium guajava on alloxan-induced diabetic rats. Pharmazie, 59, 734-735, 2004.
84. Ojewole, J.A.: Hypoglycemic and hypotensive effects of Psidium guajava Linn. (Myrtaceae) leaf aqueous extract. Methods Find. Exp. Clin. Pharmacol., 27, 689-695, 2005.
85. Mukhtar, H.M., Ansari, S.H., Bhat, Z.A., Naved, T., and Singh, P.: Antidiabetic activity of an ethanol extract obtained from the stem bark of Psidium guajava (Myrtaceae). Pharmazie, 61, 725-727, 2006.
86. Oh, W.K., Lee, C.H., Lee, M.S., Bae, E.Y., Sohn, C.B., Oh, H., Kim, B.Y., and Ahn, J.S.: Antidiabetic effects of extracts from Psidium guajava. J. Ethnopharmacol., 96, 411-415, 2005.
87. Wang, B., Liu, H.C., Hong, J.R., Li, H.G., and Huang, C.Y.: Effect of Psidium guajava leaf extract on alpha-glucosidase activity in small intestine of diabetic mouse. Sichuan Da Xue Xue Boa Yi Xue Ban, 38, 298-301, 2007.
88. Van Wyk, B.E. and Albrecht, C.: A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). J. Ethnopharmacol., 119, 620-629, 2008.
89. Ojewole, J.A.: Analgesic, antiinflammatory and hypoglycemic effects of Sutherlandia frutescens R. BR. (variety Incana E. MEY.) [Fabaceae] shoot aqueous extract. Methods Find. Exp. Clin. Pharmacol., 26, 409-416, 2004.
90. Chadwick, W.A., Roux, S., van de Venter, M., Louw, J., and Oelofsen, W.: Anti-diabetic effects of Sutherlandia frutescencs in Wistar rats fed a diabetogenic diet. J. Ethnopharmacol., 109, 121-127, 2007.